Antibiotics have made it possible to treat bacterial infections such as meningitis and
bacteraemia that, prior to their introduction, were untreatable and consequently fatal …

Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged,
disseminated globally and become a leading cause of bacterial infections in both health …

Background Bloodstream infections comprise a wide variety of pathogens and clinical
syndromes with considerable overlap with similar syndromes of non-bacteraemic infections …

Background. In vitro laboratory and animal studies demonstrate a synergistic role for the
combination of vancomycin and antistaphylococcal β-lactams for methicillin-resistant …

Antibacterial nanomaterials have attracted growing interest for bacterial infection therapy.
However, most nanomaterials eliminate bacteria either physically or chemically, which …

Background: Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of
invasive infections, mainly bloodstream infections (BSI) with or without endocarditis. The …

Genome sequencing has provided snapshots of the transmission of methicillin-resistant
Staphylococcus aureus (MRSA) during suspected outbreaks in isolated hospital wards …

Background Information on outcomes of methicillin-susceptible and-resistant
Staphylococcus aureus (MSSA and MRSA, respectively) bacteremia, particularly …

Background In addition to acute hospital mortality, sepsis is associated with higher risk of
death following hospital discharge. We assessed the strength of epidemiological evidence …

Importance Staphylococcus aureusis a frequent cause of infection in hospitalized infants.
These infections are associated with increased mortality and morbidity and longer hospital …